Common over-the-counter medication slashes colorectal cancer recurrence in half
PositiveU.S News

Recent research has revealed that a daily dose of 160 milligrams of aspirin can cut the recurrence risk of colorectal cancer in patients with specific genetic alterations by half. This finding is significant as it offers a simple, over-the-counter solution that could greatly improve outcomes for many patients, making it a potential game-changer in cancer treatment.
— Curated by the World Pulse Now AI Editorial System